Intracellular Photocatalytic NADH/NAD(P)H Oxidation for Cancer Drug Development
Ashish Yadav,
No information about this author
Samya Banerjee,
No information about this author
Arif Ali Mandal
No information about this author
et al.
Journal of the American Chemical Society,
Journal Year:
2025,
Volume and Issue:
147(9), P. 7161 - 7181
Published: Feb. 20, 2025
Photocatalytic
cancer
therapy
(PCT)
has
emerged
as
a
cutting-edge
anticancer
mechanism
of
action,
harnessing
light
energy
to
mediate
the
catalytic
oxidation
intracellular
substrates.
PCT
is
significant
current
importance
due
its
potential
address
limitations
conventional
chemotherapy,
particularly
drug
resistance
and
side
effects.
This
approach
offers
noninvasive,
targeted
treatment
option
by
utilizing
metal-based
photocatalysts
induce
redox
metabolic
disorders
within
cells.
The
disrupt
cell
metabolism
converting
NADH/NAD(P)H
NAD+/NAD(P)+
via
photoredox
processes,
altering
NAD+/NADH
or
NAD(P)+/NAD(P)H
ratios,
which
are
crucial
for
cellular
metabolism.
Ir(III),
Ru(II),
Re(I),
Os(II)
demonstrated
promising
efficacy.
Despite
these
developments,
gaps
remain
in
literature
translating
this
new
into
clinical
trials.
Perspective
critically
examines
developments
research
area
provides
future
directions
designing
efficient
PCT.
Language: Английский
An efficient ICD inducer based on Ir(III) cyclometalated complex for anticancer and anti-migration effects towards cisplatin-resistant cancer cells
Jingyue Zhao,
No information about this author
Xiangyu Dai,
No information about this author
Mengdi Lv
No information about this author
et al.
Inorganica Chimica Acta,
Journal Year:
2025,
Volume and Issue:
unknown, P. 122601 - 122601
Published: Feb. 1, 2025
Language: Английский
Overcoming Radiation-induced PD-L1 and Cox-2 Upregulation by Nitric Oxide Gas Nanogenerator to Sensitize Radiotherapy of Lung Cancer
Biomaterials,
Journal Year:
2025,
Volume and Issue:
unknown, P. 123335 - 123335
Published: April 1, 2025
Language: Английский
Gold(I) N-Heterocyclic Carbene Complexes as Ferroptosis Inducing Anticancer Agents
E. Schlegel,
No information about this author
Zisis Papadopoulos,
No information about this author
Nicolás Montesdeoca
No information about this author
et al.
ACS Medicinal Chemistry Letters,
Journal Year:
2025,
Volume and Issue:
16(5), P. 856 - 864
Published: April 24, 2025
This
study
presents
the
chemical
synthesis
and
biological
evaluation
of
a
series
gold(I)-N-heterocyclic
carbene
complexes
as
potential
anticancer
agents.
The
compounds
demonstrated
broad
activity
against
various
cancer
cell
lines,
exhibiting
cytotoxicity
in
low
micromolar
range.
Mechanistic
investigations
revealed
that
these
preferentially
accumulate
mitochondria
cells,
where
they
induce
generation
reactive
oxygen
species
lipid
peroxides,
ultimately
triggering
ferroptosis.
Further
studies
multicellular
tumor
spheroids
confirmed
compounds'
ability
to
penetrate
three-dimensional
cellular
structures
effectively
eradicate
them
at
concentrations.
work
represents
first
known
example
complex
inducing
ferroptosis,
expanding
therapeutic
gold(I)-based
metallodrugs.
Language: Английский